학술논문
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Document Type
Article
Author
Source
In The Lancet 28 June-4 July 2014 383(9936):2222-2231
Subject
Language
ISSN
0140-6736